Alzheimer's disease

Doug Whitney, center, eats breakfast with his family in Manson, Wash., on Nov. 5, 2022. Whitney inherited the same gene mutation that gave Alzheimer’s disease to his mother, brother and generations of other relatives by the unusually young age of 50. Doug is a healthy 73, his mind still sharp. Somehow, he escaped his genetic fate. (AP Photo/Shelby Lum)

Science seeking Alzheimer’s clues from few who escape genetic fate

Researchers could uncover and mimic whatever protects those who escaped fate of their families

 

First Link® Dementia Helpline can provide you with the support and answeres you need.

Stand up against dementia stigma this Alzheimer’s Awareness Month

Jana Schulz of Cranbrook, B.C. – a registered social worker, working as…

  • Jan 9, 2023

 

FILE — The Biogen Inc., headquarters is shown March 11, 2020, in Cambridge, Mass. Shares of Biogen and other drugmakers researching Alzheimer’s disease soared early Wednesday, Sept. 28, 2022, after Japan’s Eisai Co. said its potential treatment appeared to slow the fatal disease’s progress in a late-stage study. Eisai announced results late Tuesday from a global study of nearly 1,800 people with early-stage Alzheimer’s (AP Photo/Steven Senne, File)

VIDEO: Alzheimer’s drug shows promise in early results of study

Patient decline reduced by 27% in initial study

 

The Georgina Falt Memorial Trophy and a photo of Georgina, whom the tournament is named after. (Photo by Don Bodger)

Having fun and raising money the bottom line of music trivia tournament

Alzheimer’s fundraiser a No. 1 hit with supporters from around the Island

The Georgina Falt Memorial Trophy and a photo of Georgina, whom the tournament is named after. (Photo by Don Bodger)
A new study estimates that 6.3 million Canadians will be diagnosed and living with dementia in the next 30 years (Photo: Alzheimer Society)

Canada could see tripling of people living with dementia in next 30 years: Landmark study

The Alzheimer Society of Canada released a study that predicts triple the number of diagnoses

A new study estimates that 6.3 million Canadians will be diagnosed and living with dementia in the next 30 years (Photo: Alzheimer Society)
The IG Wealth Management Walk for Alzheimer’s is back in Victoria May 29 for the first time since the pandemic started. (Black Press Media file photo)

Alzheimer’s walk returning to Victoria May 29

Fundraiser for the Alzheimer’s Society of B.C. is returning for first time since start of pandemic

The IG Wealth Management Walk for Alzheimer’s is back in Victoria May 29 for the first time since the pandemic started. (Black Press Media file photo)
Brenda Brophy (left) and her mom Dorothy Finnerty share their experiences as a caregiver and person with dementia in the University of Victoria’s new podcast, Call to Mind. (Courtesy of UVic)

Greater Victoria residents’ share stories of dementia and caregiving in UVic podcast

Series fills a void with stories of love, joy as well as challenges

Brenda Brophy (left) and her mom Dorothy Finnerty share their experiences as a caregiver and person with dementia in the University of Victoria’s new podcast, Call to Mind. (Courtesy of UVic)
Neil Robertson started sharing his colouring when people were putting hearts in windows for the pandemic’s first responders. Now he rotates a gallery on his windows every couple of weeks. (Zoe Ducklow/New Staff)

Inspired artist brings colour to Langford neighbourhood

Alzheimer’s patient’s artworks provide bright, cheerful display in windows

Neil Robertson started sharing his colouring when people were putting hearts in windows for the pandemic’s first responders. Now he rotates a gallery on his windows every couple of weeks. (Zoe Ducklow/New Staff)
In this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administration approved aducanumab, the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease. (Biogen via AP)

U.S. approves much-debated Alzheimer’s drug aducanumab panned by experts

Drug from Biogen deemed “reasonably likely” to benefit Alzheimer’s patients

In this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administration approved aducanumab, the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease. (Biogen via AP)
(Black Press Media file)

Webinars help Greater Victoria residents affected by dementia prepare for the holidays

COVID-19 pandemic, restrictions can add additional challenges for people living with dementia

(Black Press Media file)
Joined by her daughter Emily (right) and the rest of their family, Kathy Collins hopes to raise awareness about early onset dementia. (Submitted)

Cowichan sisters go viral on TikTok for early onset dementia awareness efforts

It was just two years ago that Jean Collins’s sister Kathy was diagnosed with early-onset dementia.

Joined by her daughter Emily (right) and the rest of their family, Kathy Collins hopes to raise awareness about early onset dementia. (Submitted)
Alzheimer Society of B.C. brings free family resources to Greater Victoria

Alzheimer Society of B.C. brings free family resources to Greater Victoria

Series runs Saturdays this month from 9:30 a.m. to 3:30 p.m. at the Alzheimer Resource Centre

Alzheimer Society of B.C. brings free family resources to Greater Victoria
Pop-up banner image